Refractory symptomatic ventricular tachycardia and ventricular fibrillation in elderly patients. 1987

D D Tresch, and E V Platia, and T Guarnieri, and P R Reid, and L S Griffith
Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland.

The problem of refractory life-threatening ventricular tachyarrhythmias in elderly patients has not been previously studied. To determine if clinical, anatomic, or electrophysiologic variables and prognosis are significantly different in elderly subjects, 49 elderly (68 to 84 years) and 44 younger (44 to 53 years) survivors of refractory symptomatic ventricular tachycardia and/or ventricular fibrillation secondary to coronary artery disease were studied. Elderly patients displayed more extensive anatomic coronary artery disease, with 80 percent having three-vessel disease in comparison with 30 percent of the younger patients (p less than 0.001). Prior myocardial infarction, heart failure, and cardiomegaly were more common in the elderly group (p less than 0.01, p less than 0.001, and p less than 0.034, respectively), whereas angina was more common in the younger group (p less than 0.001). In 55 percent of the elderly patients and 58 percent of the younger patients, electrophysiologic testing demonstrated inducible sustained ventricular tachycardia that required treatment with an investigative antiarrhythmic drug and/or cardiac surgery, including implantation of an automatic defibrillator. Elderly patients tolerated aggressive evaluation as well as did younger patients, and despite the difference in clinical and anatomic findings, long-term survival curves were similar, although the probability of survival at 20 months was 62 percent in the elderly and 80 percent in the younger patients. This difference in early survival is explained by eight surgical deaths in the elderly group, compared with two in the younger group.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002304 Cardiac Pacing, Artificial Regulation of the rate of contraction of the heart muscles by an artificial pacemaker. Pacing, Cardiac, Artificial,Artificial Cardiac Pacing,Artificial Cardiac Pacings,Cardiac Pacings, Artificial,Pacing, Artificial Cardiac,Pacings, Artificial Cardiac
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

D D Tresch, and E V Platia, and T Guarnieri, and P R Reid, and L S Griffith
October 2016, Nursing,
D D Tresch, and E V Platia, and T Guarnieri, and P R Reid, and L S Griffith
August 1996, Journal of clinical pharmacology,
D D Tresch, and E V Platia, and T Guarnieri, and P R Reid, and L S Griffith
August 1999, Current treatment options in cardiovascular medicine,
D D Tresch, and E V Platia, and T Guarnieri, and P R Reid, and L S Griffith
July 2009, Expert review of cardiovascular therapy,
D D Tresch, and E V Platia, and T Guarnieri, and P R Reid, and L S Griffith
January 2023, Clinical case reports,
D D Tresch, and E V Platia, and T Guarnieri, and P R Reid, and L S Griffith
February 1985, Vnitrni lekarstvi,
D D Tresch, and E V Platia, and T Guarnieri, and P R Reid, and L S Griffith
May 1988, Schweizerische medizinische Wochenschrift,
D D Tresch, and E V Platia, and T Guarnieri, and P R Reid, and L S Griffith
July 2002, Nihon rinsho. Japanese journal of clinical medicine,
D D Tresch, and E V Platia, and T Guarnieri, and P R Reid, and L S Griffith
April 2019, Journal of cardiovascular electrophysiology,
D D Tresch, and E V Platia, and T Guarnieri, and P R Reid, and L S Griffith
December 1967, Annals of internal medicine,
Copied contents to your clipboard!